• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH
Click for more information
0.00% 0.5¢

ALTERITY THERAPEUTICS LIMITED - Charts / Financials

Market Cap $28.84M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

refresh Created with Sketch. REFRESH
Last update - 13.27pm 15/05/2024 (20 minute delay) ?
Day
Open 0.6¢   Day High 0.6¢   Day Low 0.5¢
Daily Volume 4868728
Bids   Sellers
Number Price Volume   Number Price Volume
45 0.5¢ 42771258   22 0.6¢ 20563308

Directors & Senior Management

Dr. David A. Stamler Chief Executive Officer
Mr. Phillip D. Hains Chief Financial Officer, Company Secretary
Mr. Geoffrey Paul Kempler Non-Executive Chairman of the Board
Mr. Lawrence B. Gozlan Non-Executive Director
Mr. Peter Ashley Marks Non-Executive Independent Director
Mr. Brian Derek Meltzer Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
0.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $28.84M
Open High Low Value Volume
0.6¢ 0.6¢ 0.5¢ $26.81K 4.868M

Buyers (Bids)

No. Vol. Price($)
45 42771258 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 20563308 22
View Market Depth
Last trade - 16.10pm 15/05/2024 (20 minute delay) ?
Last
0.5¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 1735805
Last updated 13.27pm 15/05/2024 ?

Top Stories

Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management

Industry specialist Shekel Brainweigh (ASX:SBW) has built AI into its high-tech product scale and weighing technologies.
Market Update: Materials and health push ASX up The ASX200 is up nearly 0.6 of a percent, in line with futures’ predictions.Materials and healthcare are in the lead this morning @ both sectors are up more than a percent. Energy and industrials are a drag mid-session.In other news this morning @ the Wage Price Index (WPI) rose 0...
Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing Sun Silver is enjoying a strong debut on the local bourse with shares up 100% to 40cps as miners enjoy budgetary stimulus.
Want copper with that? Boss Energy hits orange metal on-site uranium play The exploration team at Boss Energy announced on Wednesday that its latest drill run on-site has successfully found copper.
Recce Pharma heading closer to full efficacy data for flagship R327 Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial has been dosed.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.